Life Extension Ventures

Cure51 is a company focused on advancing cancer treatment through the development of a clinical and molecular database. Its primary mission is to create a comprehensive database of cancer survivors, utilizing their unique biological characteristics to identify potential drug targets. By analyzing the biology of long-term cancer survivors, Cure51 aims to aid healthcare researchers in decoding genetic information derived from biopsies, blood tests, imaging, and other samples. This innovative approach seeks to accelerate drug discovery, ultimately contributing to the formulation of new and effective cancer therapies.

IMU Biosciences is a biotechnology company focused on mapping the immune system to advance precision medicine.

Cromatic develops a software platform that facilitates outsourced R&D for life sciences companies. It streamlines the process of finding and managing scientific outsourcing partners, allowing clients to focus on core scientific work without needing their own lab infrastructure.

Hypervision Surgical develops an AI-powered hyperspectral imaging platform designed to enhance surgical precision, safety, and speed. The non-contact, non-invasive optical system splits light into multiple spectral bands to provide real-time, data-driven tissue characterization that can be visualized intraoperatively without contrast agents. This approach enables clinicians to assess tissue during procedures, potentially improving accuracy, reducing risk, and supporting decision-making throughout surgery.

Cortical Labs develops biological computer chips that integrate living neurons with silicon to enable adaptive computing systems. Its biOS technology measures neuronal activity and translates it into data to drive a digital environment, yielding self-programming capabilities and energy-efficient performance. The company aims to provide fluid intelligence and scalable computing for applications across digital spaces, robotics, science, and personal care, supporting autonomous robotics and next-generation data centers through biologically based computing platforms.

Onc.AI, Inc. is a technology company founded in 2020 and headquartered in San Carlos, California. It specializes in clinical oncology, utilizing advanced software that integrates genomics, proteomics, and radiomics to enhance oncology diagnostics. By employing deep learning techniques, Onc.AI aims to provide actionable insights that improve treatment outcomes for cancer patients. The company's innovative approach seeks to advance the field of oncology through the development of comprehensive data-driven solutions.

Exer Labs uses AI on mobile and tablet devices as well as computer vision to help fitness users experience a more interactive and affordable at-home workout.